Samhsa methadone take home guidelines

The Substance Abuse and Mental Health Services Administration (SAMHSA) and state and federal guidelines enforce take-home methadone restrictions

In response to COVID-19, the DEA and SAMHSA adopted policies to allow OTPs to increase methadone take-home dosing up to 28 days for Brand names: Subutex.

This initiated a shift from in-person visits to virtual ones and decreased the restrictions on take-home flexibilities. 1 On Ma, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidelines that allowed states to request an exception to the previously stringent requirements regarding methadone take-home

SAMHSA will revise 42 CFR part 8 to make permanent some regulatory flexibilities for opioid treatment programs to provide extended take home doses of methadone.

Currently the state's stringent regulations far surpass federal guidelines take-home doses of methadone. Previously only a methadone clinic

In response to COVID-19, the DEA and SAMHSA adopted policies to allow OTPs to increase methadone take-home dosing up to 28 days for Brand names: Subutex.

Flexibility of Methadone Medication Take-Home Doses in OTPs. In March 2024, due to the COVID-19 Pandemic, SAMHSA issued exemptions allowing OTPs to dispense up to 28 days of take-home methadone doses for stable patients being treated for OUD and up to 14 doses of take-home methadone for less stable patients.

While access to take-home methadone has improved on a federal level, some states maintain more restrictive regulations. new SAMHSA rules.

take-home methadone prescriptions that can be filled in The rule pairs increased take-home dosage with looser prescribing guidelines.